Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Journal of Translational Medicine
|
June 26, 2020
WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target
Bin Zhou, Xianghong Jin, Weiwei Jin, et al.
Acta Biomaterialia
|
April 11, 2022
Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane
Bin Liang, Dawei Jiang, Luqi Pan, et al.
American Journal of Clinical Oncology
|
February 9, 2018
Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma)
Dongfeng Zeng, Aakash Desai, Fangfang Yan, et al.
Therapeutic Advances in Hematology
|
January 30, 2026
The impact of clinical manifestations on the prognosis of diffuse large B-cell lymphoma
Siqian Wang, Xi Xu, Yongyong Ma, et al.
Clinical Therapeutics
|
August 8, 2025
Pegylated Liposomal Doxorubicin Confers a High Risk for Pneumocystis Jirovecii Pneumonia in Patients With Diffuse Large B-Cell Lymphoma
Siqian Wang, Xi Xu, Yongyong Ma, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 15, 2018
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
Haige Ye, Aakash Desai, Shengjian Huang, et al.
Scientific Reports
|
March 14, 2025
POD24-Based prognostic signature enables personalized risk stratification in mantle cell lymphoma
Yizi He, Caiqin Wang, Tao Pan, et al.
Hematological Oncology
|
April 27, 2024
Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma
Jiangfang Feng, Yue Fei, Meng Gao, et al.
Clinical Epigenetics
|
February 5, 2025
miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world setting
Yilan Xu, Danyang Li, Na Wang, et al.
Frontiers in Pharmacology
|
December 31, 2024
Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China
Rongqi Li, Yuhan Zeng, Yizhang Chen, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Journal of Translational Medicine
|
June 26, 2020
WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target
Bin Zhou, Xianghong Jin, Weiwei Jin, et al.
Acta Biomaterialia
|
April 11, 2022
Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane
Bin Liang, Dawei Jiang, Luqi Pan, et al.
American Journal of Clinical Oncology
|
February 9, 2018
Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma)
Dongfeng Zeng, Aakash Desai, Fangfang Yan, et al.
Therapeutic Advances in Hematology
|
January 30, 2026
The impact of clinical manifestations on the prognosis of diffuse large B-cell lymphoma
Siqian Wang, Xi Xu, Yongyong Ma, et al.
Clinical Therapeutics
|
August 8, 2025
Pegylated Liposomal Doxorubicin Confers a High Risk for Pneumocystis Jirovecii Pneumonia in Patients With Diffuse Large B-Cell Lymphoma
Siqian Wang, Xi Xu, Yongyong Ma, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 15, 2018
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
Haige Ye, Aakash Desai, Shengjian Huang, et al.
Scientific Reports
|
March 14, 2025
POD24-Based prognostic signature enables personalized risk stratification in mantle cell lymphoma
Yizi He, Caiqin Wang, Tao Pan, et al.
Hematological Oncology
|
April 27, 2024
Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma
Jiangfang Feng, Yue Fei, Meng Gao, et al.
Clinical Epigenetics
|
February 5, 2025
miR-182 promoter hypermethylation predicts the better outcome of AML patients treated with AZA + VEN in a real-world setting
Yilan Xu, Danyang Li, Na Wang, et al.
Frontiers in Pharmacology
|
December 31, 2024
Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China
Rongqi Li, Yuhan Zeng, Yizhang Chen, et al.
Page
of 5